MDSpire - Takeaway
FDA & Government News

FDA Drops Age Limit for Neffy

Needle-free epinephrine expands access for younger children meeting weight criteria

Share

  • 1

    Neffy nasal spray now has no minimum age for the 1 mg dose.

  • 2

    It is intended for patients weighing 33 pounds or greater.

  • 3

    Approximately 25% of patients needing epinephrine are in the 33-66 pound range.

  • 4

    Caregivers report fear of needle injections.

  • 5

    Patients should carry two devices and seek emergency care after use.

  • 6

    Neffy can be stored at temperatures up to 122 °F.

Original Source(s)

FDA Drops Age Limit for Neffy

  • by Kathryn Wighton

  • March 27, 2026

Related Content

FDA Approves Gene Therapy for Severe Pediatric LAD-I

Approval expands treatment option for a rare pediatric immunodeficiency

Meningococcal Abscess Detected by MRI

MRI identifies rare intracranial complication following normal computed tomography

UTICalc 3.0 Shows Promise for UTI Risk

Online risk tool may help guide urine testing decisions